Product Information

CAPECITABINE 150 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.3955 per EA under NDC 16714046701. Its NADAC has been published 121 times since Mar 9, 2016.

FDA first approved this application on Apr 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CAPECITABINE 150 MG TABLET

CAPECITABINE
$0.3955per EA
Discontinued

Strength

150 mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714046701

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

12/17/2025

Active Ingredients

CAPECITABINE

Approval Type

Generic (ANDA)

FDA Application

ANDA202593

FDA Approved

4/23/2015

TE Code

AB

On Market Since

11/1/2015

Pharmacological Classes

Nucleic Acid Synthesis Inhibitors
Nucleoside Metabolic Inhibitor

Price Statistics

The NADAC for CAPECITABINE 150 MG TABLET has been published 121 times since Mar 9, 2016, and over the history we have for it it has declined 94.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3955 per EA
All-time high$7.2449 (Aug 10, 2016)
All-time low$0.2292 (Mar 19, 2025)
52-week high$0.4038
52-week low$0.3955
Median price$0.3955
Average price$1.6718
Largest weekly change-92.6% (May 22, 2024)
Weeks tracked121
Tracking sinceMar 9, 2016

Price History

1W

N/A

1M

N/A

3M

N/A

6M

0.0%

1Y

-2.1%

3Y

-94.5%

5Y

-94.5%

All

-94.5%

Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CAPECITABINE 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CAPECITABINE 150 MG TABLET, manufactured by NorthStar Rx LLC, is $0.3955 per EA (NDC 16714046701), effective Apr 1, 2026.

How has the price of CAPECITABINE 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for CAPECITABINE 150 MG TABLET has declined 94.5%. It has been tracked across 121 weekly CMS publications since Mar 9, 2016.

What are the highest and lowest recorded NADAC prices for CAPECITABINE 150 MG TABLET?

Since Mar 9, 2016, the NADAC for CAPECITABINE 150 MG TABLET has ranged from a low of $0.2292 (Mar 19, 2025) to a high of $7.2449 (Aug 10, 2016), with a median of $0.3955 per EA.

Are there cheaper alternatives to CAPECITABINE 150 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CAPECITABINE 150 MG TABLET, is $0.3615 per EA — about 9% below CAPECITABINE 150 MG TABLET.

Who manufactures CAPECITABINE 150 MG TABLET?

CAPECITABINE 150 MG TABLET (NDC 16714046701) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.